Diamondback Advisors

Diamondback Advisors, primarily known as Diamondback Capital Management, was a prominent hedge fund based in Stamford, Connecticut, that focused significantly on the healthcare and life sciences sectors. Founded in 2005 by Richard Schimel and Lawrence Sapanski, the firm managed billions in assets and employed a large team of specialized analysts to identify investment opportunities in biotechnology, pharmaceuticals, and medical technology. Although it was a major player in healthcare investing for several years, the firm shuttered its operations in late 2012 following a high-profile insider trading investigation. During its peak, Diamondback was recognized for its deep fundamental research and its influence as a capital provider for emerging and established life science companies.